NCT04467892View on ClinicalTrials.gov

Low Versus High Corticosteroid Use in Ventilator Associated Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

February 14, 2020

Study Completion Date

February 25, 2020

Conditions
Ventilator Associated Pneumonia
Interventions
DRUG

methylprednisolone

received high dose (30 mg/kg) methylprednisolone slowly intravenous in 250 ml normal saline every 8 hours for only 4 days

DRUG

Methyl Prednisolonate

received 1 mg/kg/day methylprednisolone divided to three doses given every 8 hours for two weeks.

DEVICE

ventilators

all patients in both groups will be ventilated with CMV for 2 weeks

Trial Locations (1)

21944

King abd el Aziz specialist hospital, Ta'if

All Listed Sponsors
lead

King Abdul Aziz Specialist Hospital

NETWORK

NCT04467892 - Low Versus High Corticosteroid Use in Ventilator Associated Pneumonia | Biotech Hunter | Biotech Hunter